Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects (Q40795448)

23 September 2017

1 reference

title

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects (English)

1 reference

23 September 2017

1 reference

1

1 reference

23 September 2017

1 November 1993

1 reference

23 September 2017

1 reference

23 September 2017

36

1 reference

23 September 2017

1119-1125

1 reference

23 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00401055

23 September 2017

0 references

cites work

Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus

1 reference

12 December 2020

Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanisms of diabetic vascular complications

1 reference

12 December 2020

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

12 December 2020

Vascular thrombosis in type II diabetes mellitus

1 reference

12 December 2020

Blood glucose may condition factor VII levels in diabetic and normal subjects.

1 reference

12 December 2020

The Role of Hyperglycaemia-induced Alterations of Antithrombin III and Factor X Activation in the Thrombin Hyperactivity of Diabetes Mellitus

1 reference

12 December 2020

Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice

1 reference

12 December 2020

Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy

1 reference

12 December 2020

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

1 reference

12 December 2020

Hyperglycemia may determine fibrinopeptide A plasma level increase in humans

1 reference

12 December 2020

Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

1 reference

12 December 2020

Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes

1 reference

12 December 2020

Low molecular weight heparin restores antithrombin III activity from hyperglycemia induced alterations.

1 reference

12 December 2020

Induced Hyperglycemia Alters Antithrombin III Activity but not its Plasma Concentration in Healthy Normal Subjects

1 reference

12 December 2020

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

1 reference

12 December 2020

Biological Effects of ω-3 Fatty Acids in Diabetes Mellitus

1 reference

12 December 2020

Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial

1 reference

12 December 2020

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

12 December 2020

Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria.

1 reference

12 December 2020

Nonenzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by Plasmin

1 reference

12 December 2020

Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma

1 reference

12 December 2020

Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state

1 reference

12 December 2020

Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose

1 reference

12 December 2020

Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics

1 reference

12 December 2020

Contrasting Fibrinolytic Responses in Type 1 (Insulin-dependent) and Type 2 (Non-insulin-dependent) Diabetes

1 reference

12 December 2020

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

12 December 2020

Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species

1 reference

12 December 2020

Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.

1 reference

12 December 2020

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

1 reference

12 December 2020

Sulfonylureas and platelet function

1 reference

12 December 2020

Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease

1 reference

12 December 2020

Red blood cell volume and glycaemic control in diabetes

1 reference

12 December 2020

In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug

1 reference

12 December 2020

Metabolic Control May Alter Antithrombin III Activity but Not Its Plasma Concentration in Diabetes: A Possible Role for Nonenzymatic Glycosylation

1 reference

12 December 2020

Measurement of fibrinopeptide A in human blood

1 reference

12 December 2020

Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats

1 reference

12 December 2020

Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

Increased prothrombin fragment 1 + 2 in type I diabetic patients

1 reference

12 December 2020

Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans

1 reference

12 December 2020

Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects

1 reference

12 December 2020

Effects of IGF-I and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture

1 reference

12 December 2020

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

1 reference

12 December 2020

Reduced negative surface charge on arterial endothelium of diabetic rats

1 reference

12 December 2020

Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro

1 reference

12 December 2020

Inhibition of antithrombin III by lipid peroxides

1 reference

12 December 2020

Factors of the hemostatic system in diabetic patients. A survey of controlled studies

1 reference

12 December 2020

Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity

1 reference

12 December 2020

The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study

1 reference

12 December 2020

Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins Ala-c

1 reference

12 December 2020

Platelets from diabetic subjects show diminished sensitivity to prostacyclin

1 reference

12 December 2020

Glycosylated haemoglobin and reticulocyte count in diabetes

1 reference

12 December 2020

Role of oxidative stress in development of complications in diabetes

1 reference

12 December 2020

Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients

1 reference

12 December 2020

Metabolic control may influence the increased superoxide generation in diabetic serum.

1 reference

12 December 2020

Platelet fibrinogen binding in diabetes mellitus. Differences between binding to platelets from nonretinopathic and retinopathic diabetic patients

1 reference

12 December 2020

Fibrinopeptide A and platelet factor levels in unstable angina pectoris

1 reference

12 December 2020

Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic control

1 reference

12 December 2020

Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activity

1 reference

12 December 2020

Hematologic alterations in diabetes mellitus

1 reference

12 December 2020

Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report

1 reference

12 December 2020

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

1 reference

12 December 2020

Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients

1 reference

12 December 2020

The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro

1 reference

12 December 2020

Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon.

1 reference

12 December 2020

Modification of tissue-factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells

1 reference

12 December 2020

Glucose inhibits prostacyclin production by cultured aortic endothelial cells

1 reference

12 December 2020

Endothelium and regulation of coagulation

1 reference

12 December 2020

Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity

1 reference

12 December 2020

Thromboxane biosynthesis and platelet function in type I diabetes mellitus

1 reference

12 December 2020

Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus

1 reference

12 December 2020

alpha1-Macroglobulin and reduced basement-membrane degradation in diabetes

1 reference

12 December 2020

Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E

1 reference

12 December 2020

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

12 December 2020

Cardiovascular Effects of n-3 Fatty Acids

1 reference

12 December 2020

Diabetes and cardiovascular disease. The Framingham study

1 reference

12 December 2020

Platelet aggregate ratio in diabetes mellitus

1 reference

12 December 2020

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Association between the glycation of erythrocyte membrane proteins and membrane fluidity

1 reference

12 December 2020

New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications

1 reference

12 December 2020

Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide

1 reference

12 December 2020

Evidence for a reduced heparin cofactor II biological activity in diabetes.

1 reference

12 December 2020

Decreased protein C levels in patients with insulin-dependent type I diabetes mellitus

1 reference

12 December 2020

Plama-thromboglobulin concentrations in diabetes mellitus

1 reference

12 December 2020

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study

1 reference

12 December 2020

Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes

1 reference

12 December 2020

Lipoprotein(a) reduction by N-acetylcysteine

1 reference

12 December 2020

Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients

1 reference

12 December 2020

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control

1 reference

12 December 2020

Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients

1 reference

12 December 2020

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00401055

1 reference

23 September 2017

1 reference

PubMed ID

8270125